Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hiroshi Kasanuki, MD"'
Publikováno v:
Journal of Arrhythmia, Vol 29, Iss 5, Pp 249-254 (2013)
Background: Nifekalant, a first-line drug for the treatment of ventricular tachycardia/ventricular fibrillation (VT/VF) in Japan, has been known to prolong the QT interval; however, the incidence of excess QT/QTc prolongation and subsequent torsades
Externí odkaz:
https://doaj.org/article/156851b4c4804ec6a934dbebac0210a4
Autor:
Takao Katoh, MD, Satoshi Ogawa, MD, Iwao Yamaguchi, MD, Hiroshi Kasanuki, MD, Hirokazu Hayakawa, MD
Publikováno v:
Journal of Arrhythmia, Vol 23, Iss 2, Pp 131-139 (2007)
Introduction: Amiodarone infusion has been recommended for life-threatening ventricular arrhythmias. However its effectiveness in Japanese patients has not yet been determined. Methods: This was an uncontrolled, open-label trial involving patients wi
Externí odkaz:
https://doaj.org/article/56e2d287faf74f39abbb15fc537180b7
Autor:
Yutaka Kubo, MD, Shogo Murakami, MD, Kuniaki Otsuka, MD, Tsuyoshi Shiga, MD, Shin Irie, MD, Hiroshi Kasanuki, MD
Publikováno v:
Journal of Arrhythmia, Vol 21, Iss 5, Pp 528-535 (2005)
In a new drug development, regulatory authorities recommend the “thorough QT/QTc study”, in which the use of a positive control group was recommended for evaluating assay sensitivity that allows the detection of a QT/QTc interval prolongation abo
Externí odkaz:
https://doaj.org/article/51a8ca325fd54143a5e910e7767cf2fd